Noteworthy News

17 Dec 2015

BTG boss scans for next deals as lung device bet pays off 

After being vindicated in her 2014 purchase of a U.S. company with a device to prop open diseased lungs, the chief executive of British healthcare group BTG (BTG.L) is scouring the horizon for the next promising acquisition.

29 Sep 2015

Eisai Receives Additional Approval in Japan for Vascular Embolisati...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that it has received additional approval for the vascular embolization device DC Bead® (specially controlled medical device, “DC Bead”) to be used for the treatment of hypervascular tumors and arteriovenous malformations (AVM) in Japan.

29 Sep 2015

Creating a 'Contagious' Corporate Culture

The recent New York Times article on Amazon's "bruising workplace" sparked a firestorm of reaction.

5 Sep 2015

Millions of tiny beads help liver cancer patients

BILLINGS – Millions of tiny glass beads have given some liver cancer patients in Billings another option in their fight against the disease.

28 Apr 2015

UK Trial of radioactive glass particles to tackle cancer

Cancer treatment with radioactive glass microspheres is to be trialled for the first time in the UK at Oxford's Churchill Hospital.

22 Apr 2015

Banner - University Medical Center Phoenix named Center of Excellen...

Banner - University Medical Center Phoenix has been named the West Coast Center of Excellence for TheraSphere®, a microsphere liver cancer treatment. The Phoenix hospital is one of only three locations in the United States to earn the prestigious recognition for radioembolization procedures and will be a training site for physicians throughout the country.

13 Feb 2015

DVT: Fixing Clots, Saving Lives

DVT: Fixing Clots, Saving Lives